By Adriano Marchese Opthea Ltd. said Tuesday that the U.S. Food and Drug Administration has granted a Fast Track designation to its OPT-302 treatment for patients with neovascular age-related...
MELBOURNE, Australia, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a developer of novel biologic therapies for the treatment of eye diseases, announced today the dosing of the...
RNS Number:0128T Ocean Power Technologies Inc 09 December 2003 For Immediate Release 9 December 2003 OCEAN POWER TECHNOLOGIES ANNOUNCES INTERIM RESULTS FOR THE SIX MONTHS ENDED 31...
RNS Number:4870S Ocean Power Technologies Inc 26 November 2003 Ocean Power Technologies, Inc. 1590 Reed Road Pennington, New Jersey 08534 Pennington, NJ USA USA For Immediate Release...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.155 | 20.5298013245 | 0.755 | 0.915 | 0.725 | 2212618 | 0.79819861 | DE |
4 | 0.17 | 22.972972973 | 0.74 | 0.915 | 0.725 | 1489007 | 0.78583414 | DE |
12 | 0.05 | 5.81395348837 | 0.86 | 0.915 | 0.595 | 1745834 | 0.72977894 | DE |
26 | 0.5275 | 137.908496732 | 0.3825 | 0.955 | 0.38 | 2749093 | 0.69498513 | DE |
52 | 0.395 | 76.6990291262 | 0.515 | 0.955 | 0.335 | 1877886 | 0.64534707 | DE |
156 | -0.39 | -30 | 1.3 | 1.395 | 0.3125 | 870634 | 0.68834478 | DE |
260 | -2.51 | -73.3918128655 | 3.42 | 3.74 | 0.3125 | 787747 | 1.14494349 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.